A cannabidiol-sensitive region involved in the allosteric modulation of the α7 nicotinic receptor
Регион, чувствительный к каннабидиолу, участвующий в аллостерической модуляции α7 никотинового рецептора
2026-06-15
SCID: 54.1/aj9g5gpn
Discuss with AI
M4-L487A mutationallosteric modulationcannabidiol-sensitive regionmolecular dynamics simulationsα7 nicotinic acetylcholine receptor
Figures from the paper
Abstract (AI)
, modulates the α7 nicotinic acetylcholine receptor (α7 nAChR), a key target in neurological, neurodegenerative, and inflammatory disorders. However, the molecular basis of this modulation remains unresolved. By combining single-channel recordings, molecular dynamics (MD) simulations, and targeted mutagenesis, we identify an allosteric region governing CBD action. CBD produces a marked inhibition of α7 channel activity, followed by a recovery phase characterized by infrequent prolonged openings. MD simulations in closed and desensitized conformations reveal partially overlapping putative CBD-binding sites at the extracellular end of the transmembrane domain. Mutations in M1 and M4 residues within these sites differentially reshape CBD modulation: Some attenuate its inhibitory action, whereas others potentiate the increase in open-channel duration. Strikingly, the M4-L487A mutation converts CBD into a strong positive allosteric modulator, demonstrating that subtle perturbations of this region can invert the direction of modulation. Functional outcomes do not map to discrete sites, indicating that CBD engages an extended allosteric network involved in CBD dual modulation. These findings identify a CBD-sensitive regulatory region, define molecular basis of α7 modulation by CBD, and provide a framework for designing next-generation modulators of pentameric ligand-gated ion channels.
Key Findings
1
CBD markedly inhibits α7 nAChR channel activity and is followed by a recovery phase with infrequent prolonged openings.
2
Functional effects of CBD do not map to discrete sites, indicating CBD engages an extended allosteric network underlying its dual modulatory actions.
3
MD simulations identify partially overlapping putative CBD-binding sites at the extracellular end of the transmembrane domain in closed and desensitized conformations.
4
Mutations in M1 and M4 residues within the identified sites differentially reshape CBD modulation: some mutations attenuate inhibition while others potentiate increased open-channel duration.
5
The M4-L487A mutation converts CBD from an inhibitor into a strong positive allosteric modulator of α7, showing that subtle perturbations can invert modulation direction.
Research Object
α7 nicotinic acetylcholine receptor (α7 nAChR)
Research Subject
A cannabidiol (CBD)-sensitive allosteric region at the extracellular end of the transmembrane domain governing CBD modulation, including effects on channel inhibition, recovery with prolonged openings, CBD-binding sites, and impact of M1/M4 mutations (e.g., M4-L487A) that reshape or invert modulation
Publication Details
Publication Date
2026-06-15
Journal
Publisher
ISSN
Cited by
1
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest